IndexBox sees replacements driving a third of quantum cascade laser shipments by 2030
The quantum cascade laser market is projected to grow 8% to 12% a year through 2035, driven by mid-infrared spectroscopy in process control, environmental monitoring and pharmaceutical quality checks. In these uses, the lasers offer high spectral brightness and run at room temperature in compact form factors. The installed base of analytical instruments is also growing.
This story was produced through MarketScale. See how Sciences teams put it to work with Executive Thought Leadership.
Key takeaways
Roughly one in three quantum cascade lasers shipped in 2030 is projected to replace equipment already in service, so maintenance calendars will set a growing share of demand.
For a plant or QA lab running QCL-based analyzers, the useful question is which laser maker sits inside each instrument and whether a second source exists.
Analyzers bought on a three-to-five-year cycle in 2026 come due between 2029 and 2031. Those years will show whether the forecast replacement wave turns up in real orders.
Free workspace
Turn your Sciences expertise into content.
Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.
One in three. IndexBox expects that share of annual quantum cascade laser shipments to come from replacement demand by 2030, according to its market report updated on October 22, 2026. The same report puts the market's baseline growth at 8% to 12% a year through 2035.
Quantum cascade lasers, or QCLs, are the mid-infrared light sources inside a growing class of analytical instruments. The headline growth rate gets the attention. The replacement figure tells an engineer who specifies an analyzer for a process line, or a pharma QA manager who runs a bank of them, more useful things: how often they will be back in the market, and how few companies they will be buying from.
Where the mid-infrared demand comes from
IndexBox links the forecast to faster adoption of mid-infrared spectroscopy in three settings: industrial process control, environmental monitoring and pharmaceutical quality assurance. The report says QCLs win those jobs on high spectral brightness and room-temperature operation in compact form factors.
Those traits point to instruments that work outside a climate-controlled lab, on a production line or at a monitoring site, where cooling hardware and bulk count against a design. That reading is an inference from the properties the report lists, not a deployment count. It still helps explain why the report sees demand spreading across several industries at once.
The quantum cascade laser outlook in four figures
IndexBox
A demand layer set by maintenance calendars
The replacement math is simple. IndexBox says the installed base of analytical instruments is growing, and that replacement cycles of three to five years create a recurring layer of demand on top of new installations. As the installed base grows, each year's replacement pool grows with it.
If IndexBox's projection holds, roughly one in three quantum cascade lasers shipped in 2030 will go to replacing equipment already in service, a demand stream set by maintenance calendars.
If IndexBox's projection holds, roughly one in three quantum cascade lasers shipped in 2030 will go to replacing equipment already in service, a demand stream set by maintenance calendars.
In practice, an analyzer bought this year on a three-to-five-year cycle comes due somewhere between 2029 and 2031, by simple arithmetic on the cycle length. A plant or lab installing QCL-based instruments in 2026 is effectively booking its next purchase now. That makes the refresh a budget line worth planning against, not a surprise.
The forecast has a limit. The replacement share depends on the installed base continuing to grow. If adoption in process control or pharma QA slowed, the recurring layer would shrink along with new orders. The one-third figure is a projection for 2030, not a measured share today.
Fewer than ten makers
Supply is the other half of the story. IndexBox says supply remains concentrated among fewer than ten specialized manufacturers with dedicated epitaxial production. That is a short list for a market the same report expects to expand by 8% to 12% a year for the next decade.
The report also describes the market entering 2026 with a more regionally diversified supply architecture, alongside broader demand fundamentals and more disciplined procurement behavior. Those descriptions don't contradict each other. A small number of makers can still spread production across regions, which suggests the more useful question for a buyer is not how many suppliers exist but where a given laser comes from and what the alternative would be.
Concentration matters most for the replacement layer. An instrument due for refresh between 2029 and 2031 would draw on the same small pool of laser makers, so the source an instrument vendor picks today could shape the options at the next cycle. The report's note on more disciplined procurement fits that reading: when there are few sources, the time to ask about them is at the first purchase, not the second.
Before signing for a new QCL-based analyzer, ask the instrument vendor who makes the laser source, where it is produced, and whether a qualified second source exists for replacements three to five years out.
Putting an 8, 12% forecast in context
A four-point forecast range is wide, and laser market forecasts in general vary a lot depending on how the market is drawn. Mordor Intelligence expects the industrial laser system market to grow from $6.71 billion in 2026 to $8.72 billion by 2031, a 5.38% CAGR over 2026-2031. Fortune Business Insights projects the industrial lasers market to grow from $26.95 billion in 2026 to $70.02 billion by 2034, a 12.70% CAGR over the forecast period.
The two 2026 bases differ by roughly a factor of four. Fortune values its market at USD 23.9 billion in 2025, against Mordor's USD 6.37 billion for the same year, so Fortune's starting point already sits well above Mordor's 2031 endpoint. The gap suggests how much a forecast depends on which products and buyers it counts.
The demand drivers differ too. Mordor ties its industrial laser growth to manufacturers switching from mechanical to laser-based tools, semiconductor fabs adding sub-micron via-hole capability and battery gigafactories standardizing laser welding. Those are capital-equipment decisions tied to new factory investment. The IndexBox QCL case rests on analytical instruments and their refresh cycle, which suggests its demand would track instrument fleets more than factory build-outs.
The industrial laser forecasts above cover lasers used to cut, weld, mark and engrave materials. The IndexBox forecast covers quantum cascade lasers used as light sources in mid-infrared spectroscopy. The figures sit side by side here to show how forecasts vary, not as one market.
For QCL buyers, the takeaway is to treat 8% to 12% as a direction, not a price signal. The real test comes earlier than 2035: instruments bought in this cycle reach their three-to-five-year mark from 2029 on. That is when the replacement layer either shows up in shipments or doesn't.
Sources
Featured companies
Your experts belong here
Every story in MarketScale Sciences starts with a company putting its lab directors, applications scientists, and field specialists on the record. Buyers are already reading this topic. The only question is whose experts they find.
Lab and research buyers verify before they trial, and your scientists give them something credible to verify against.
About the author
The MarketScale Newsroom reports on the companies, technologies, and trends shaping 16 B2B industries. It turns primary sources and expert commentary into clear, useful coverage for the people doing the work.
